| 1 |
2024 |
Danmei Zhang, Klara Dorman, C. Benedikt Westphalen, Michael Haas, Steffen Ormanns, Jens Neumann, Max Seidensticker, Jens Ricke, Enrico N. De Toni, Frederick Klauschen, Hana Algül, Timo Reisländer, Stefan Boeck, Volker Heinemann. Unresectable biliary tract cancer: Current and future systemic therapy, European Journal of Cancer. 2024; 203: 114046114046.
https://doi.org/10.1016/j.ejca.2024.114046 |
| 2 |
2024 |
Laura Alaimo, Sara Boggio, Giovanni Catalano, Giuseppe Calderone, Edoardo Poletto, Mario De Bellis, Tommaso Campagnaro, Corrado Pedrazzani, Simone Conci, Andrea Ruzzenente. Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis, Cancers. 2024; 16: 2596.
https://doi.org/10.3390/cancers16142596 |
| 3 |
2023 |
Silvia De Siervi, Cristian Turato. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer, International Journal of Molecular Sciences. 2023; 24: 4529.
https://doi.org/10.3390/ijms24054529 |
| 4 |
2023 |
Julie Weigner, Raewyn Billings, Rodney J. Scott, Simon King. The utilisation of digital droplet PCR to enhance the diagnosis of bladder and pancreaticobiliary tumours in cytology specimens, Diagnostic Cytopathology. 2023; 51: 511.
https://doi.org/10.1002/dc.25151 |
| 5 |
2023 |
Lorenza Rimassa, Giovanni Brandi, Monica Niger, Nicola Normanno, Davide Melisi. Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement, Critical Reviews in Oncology/Hematology. 2023; 192: 104146104146.
https://doi.org/10.1016/j.critrevonc.2023.104146 |
| 6 |
2024 |
Owen McGreevy, Mohammed Bosakhar, Timothy Gilbert, Marc Quinn, Stephen Fenwick, Hassan Malik, Christopher Goldring, Laura Randle. The importance of preclinical models in cholangiocarcinoma, European Journal of Surgical Oncology. 2024; 108304108304.
https://doi.org/10.1016/j.ejso.2024.108304 |
| 7 |
2024 |
William A. Preston, Esther Drill, Thomas Boerner, Rebecca Gelfer, James J. Harding, Eileen M. O'Reilly, Andrea Cercek, Ghassan Abou-Alfa, Wungki Park, Vinod P. Balachandran, Jeffrey Drebin, Kevin C. Soares, Alice Wei, T. Peter Kingham, Michael I. D'Angelica, William R. Jarnagin. Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome, JCO Precision Oncology. 2024; e2400206.
https://doi.org/10.1200/PO.24.00206 |
| 8 |
2024 |
Qi Liu, Chen‐Song Huang, Siyun Chen, Ying‐Qin Zhu, Xi‐Tai Huang, Guang‐Yin Zhao, Qiong‐Cong Xu, Yin‐Hao Shi, Wen Li, Ruizhi Wang, Xiao‐Yu Yin. ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A‐to‐I editing manner, Cell Proliferation. 2024; 57: e13659.
https://doi.org/10.1111/cpr.13659 |
| 9 |
2023 |
Maria De Bonis, Francesco Mannavola, Lisa Salvatore, Elisa De Paolis, Camilla Nero, Luciano Giacò, Giampaolo Tortora, Felice Giuliante, Andrea Urbani, Giovanni Scambia, Nicola Normanno, Angelo Minucci. Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications, Molecular Biology Reports. 2023; 50: 7113.
https://doi.org/10.1007/s11033-023-08588-x |
| 10 |
2024 |
Nicholas Prabhakar, Harrah Chiang, Edward Nabrinsky, John Eklund. Report of Cholangiocarcinoma With Transheterozygous BRCA1 and BRCA2 Co-mutation, Cureus. 2024;
https://doi.org/10.7759/cureus.60767 |
| 11 |
2023 |
Stavros P. Papadakos, Ioanna E. Stergiou, Nikolina Gkolemi, Konstantinos Arvanitakis, Stamatios Theocharis. Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications, Cancers. 2023; 15: 3434.
https://doi.org/10.3390/cancers15133434 |
| 12 |
2023 |
Maria De Bonis, Francesco Mannavola, Lisa Salvatore, Elisa De Paolis, Camilla Nero, Luciano Giaco', Giampaolo Tortora, Felice Giuliante, Andrea Urbani, Giovanni Scambia, Nicola Normanno, Angelo Minucci. 2023;
https://doi.org/10.21203/rs.3.rs-2880020/v1 |
